Management of COPD Patients with Bullae
Pharmacologic Therapy
- The American College of Physicians recommends inhaled bronchodilators as first-line therapy for stable COPD patients with respiratory symptoms and FEV1 <60% predicted 1, 2
- Monotherapy using either long-acting inhaled anticholinergics or long-acting inhaled β-agonists is recommended for symptomatic COPD patients with FEV1 <60% predicted 2
- Choice of specific monotherapy should be based on patient preference, cost, and adverse effect profile 2
Pulmonary Rehabilitation
- Pulmonary rehabilitation improves health status and dyspnea in patients with FEV1 <50% predicted 3
- For COPD patients with bullae, standard pulmonary rehabilitation without incentive spirometry is safer and still effective 4
Oxygen Therapy
- Supplemental oxygen reduces mortality rates among symptomatic patients with resting hypoxemia 3, 5
- Long-term oxygen therapy shows a reduction in mortality for patients with severe resting hypoxemia 1
Management Options for Bullae in COPD
- Bullectomy may be considered for patients with giant bullae (occupying >1/3 of hemithorax) surrounded by relatively normal parenchyma 6
- Lung Volume Reduction Surgery (LVRS) should be considered for patients with upper-lobe predominant emphysema and low exercise capacity 6
- Patients with homogeneous emphysema and good exercise capacity should not undergo LVRS due to higher mortality risk 6
- LVRS is contraindicated in patients with FEV1 ≤20% predicted with either homogeneous emphysema on HRCT or DLCO ≤20% predicted 6
Important Considerations for COPD Management
- Spirometry should be obtained to diagnose airflow obstruction in patients with respiratory symptoms but should not be used to screen for airflow obstruction in individuals without respiratory symptoms 1, 7
- All current smokers should receive smoking cessation counseling and be offered pharmacologic therapies to increase cessation rates 7
- All patients 50 years of age or older should be offered influenza vaccine annually 7